These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11533315)

  • 21. [Glutamine--its metabolic role and possibilities for clinical use].
    Turczynowski W; Szczepanik AM; Garlicki J; Mocny G
    Przegl Lek; 1998; 55(12):659-62. PubMed ID: 10354717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamine nutrition and requirements.
    Smith RJ; Wilmore DW
    JPEN J Parenter Enteral Nutr; 1990; 14(4 Suppl):94S-99S. PubMed ID: 2119461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in glutamine delivery.
    Fürst P
    J Nutr; 2001 Sep; 131(9 Suppl):2562S-8S. PubMed ID: 11533314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined infusion of glutamine and arginine: does it make sense?
    Coëffier M; Déchelotte P
    Curr Opin Clin Nutr Metab Care; 2010 Jan; 13(1):70-4. PubMed ID: 19904200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamine supplementation in acute pancreatitis: a meta-analysis of randomized controlled trials.
    Asrani V; Chang WK; Dong Z; Hardy G; Windsor JA; Petrov MS
    Pancreatology; 2013; 13(5):468-74. PubMed ID: 24075510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consequences of the REDOXS and METAPLUS Trials: The End of an Era of Glutamine and Antioxidant Supplementation for Critically Ill Patients?
    van Zanten AR; Hofman Z; Heyland DK
    JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):890-2. PubMed ID: 25567781
    [No Abstract]   [Full Text] [Related]  

  • 27. [Guidelines for specialized nutritional and metabolic support in the critically ill-patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): severe acute pancreatitis].
    Bordejé Laguna L; Lorencio Cárdenas C; Acosta Escribano J;
    Med Intensiva; 2011 Nov; 35 Suppl 1():33-7. PubMed ID: 22309750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of L-glutamine in critical illness: new insights.
    Kelly D; Wischmeyer PE
    Curr Opin Clin Nutr Metab Care; 2003 Mar; 6(2):217-22. PubMed ID: 12589192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy.
    Ziegler TR
    J Nutr; 2001 Sep; 131(9 Suppl):2578S-84S; discussion 2590S. PubMed ID: 11533316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamine-containing dipeptides in parenteral nutrition.
    Fürst P; Albers S; Stehle P
    JPEN J Parenter Enteral Nutr; 1990; 14(4 Suppl):118S-124S. PubMed ID: 2119457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): patient with sepsis].
    Ortiz Leyba C; Montejo González JC; Vaquerizo Alonso C;
    Med Intensiva; 2011 Nov; 35 Suppl 1():72-6. PubMed ID: 22309758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial.
    Zhou YP; Jiang ZM; Sun YH; Wang XR; Ma EL; Wilmore D
    JPEN J Parenter Enteral Nutr; 2003; 27(4):241-5. PubMed ID: 12903886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2007 ESPEN Sir David Cuthbertson Lecture: amino acids between and within organs. The glutamate-glutamine-citrulline-arginine pathway.
    Deutz NE
    Clin Nutr; 2008 Jun; 27(3):321-7. PubMed ID: 18501998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The route of administration (enteral or parenteral) affects the conversion of isotopically labeled L-[2-15N]glutamine into citrulline and arginine in humans.
    Ligthart-Melis GC; van de Poll MC; Dejong CH; Boelens PG; Deutz NE; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2007; 31(5):343-48; discussion 349-50. PubMed ID: 17712141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.
    Carroll PV; Jackson NC; Russell-Jones DL; Treacher DF; Sönksen PH; Umpleby AM
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E151-7. PubMed ID: 12759221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for attenuating protein-catabolic responses in the critically ill.
    Ziegler TR; Gatzen C; Wilmore DW
    Annu Rev Med; 1994; 45():459-80. PubMed ID: 8198396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic and immune effects of dietary arginine, glutamine and omega-3 fatty acids supplementation in immunocompromised patients.
    Chuntrasakul C; Siltharm S; Sarasombath S; Sittapairochana C; Leowattana W; Chockvivatanavanit S; Bunnak A
    J Med Assoc Thai; 1998 May; 81(5):334-43. PubMed ID: 9623033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutrient modification of inflammatory mediator production.
    Lowry SF; Thompson WA
    New Horiz; 1994 May; 2(2):164-74. PubMed ID: 7922441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glutamine supplemented nutrition in clinical practice--use of glutamine-containing dipeptides].
    Fürst P; Stehle P
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):317-24. PubMed ID: 8924747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamine: do the data support the cause for glutamine supplementation in humans?
    Alpers DH
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S106-16. PubMed ID: 16473057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.